A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report

Research output: Contribution to journalArticleResearchpeer-review

110 Citations (Scopus)

Abstract

Few studies have reported large inter-observer variations in target volume selection and delineation in patients treated with radiotherapy for head and neck squamous cell carcinoma. Consensus guidelines have been published for the neck nodes (see Grégoire et al., 2003, 2014), but such recommendations are lacking for primary tumour delineation. For the latter, two main schools of thoughts are prevailing, one based on geometric expansion of the Gross Tumour Volume (GTV) as promoted by DAHANCA, and the other one based on anatomical expansion of the GTV using compartmentalization of head and neck anatomy.
Original languageEnglish
Pages (from-to)206-225
Number of pages19
JournalEuropean Journal of cancer
Volume81
DOIs
Publication statusE-pub ahead of print - Jun 2017

Keywords

  • Low grade glioma
  • Childhood
  • Chemotherapy
  • Randomised trial

Fingerprint

Dive into the research topics of 'A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report'. Together they form a unique fingerprint.

Cite this